The Latest Breaking News from FDA

As of June 2024, 14 states have near-total bans on mifepristone. The other 36 states and Washington, DC, provide some form of legal access to the abortion medication.

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

Women getting help for reproductive care out of state are under siege.

TikTok does not allow searches for ‘Benadryl’ on app

Since the overturning of Roe v. Wade in June 2022 and the end of constitutional protection for abortion, emergency contraception has become more difficult to obtain and – more than ever – shrouded in misinformation.

Officials who often get it wrong can’t be trusted to reliably decree what’s true.

Galaxy Watch 5 users who use the Cycle Tracking feature in Samsung Health can now get better insights on their cycle and ovulation based on skin-temperature data collected by their smartwatch and the FDA-certified Natural Cycles algorithm.

The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the U.S. while a lawsuit continues

This list of the best sunscreens for your face has been compiled by Wallpaper* editors Mary Cleary and Hannah Tindle, who are highly selective about SPF

The new drug looked so promising — except for that one warning sign.

There is hope in the news that the leading version of naloxone, the No. 1 drug used to reverse opioid overdoses, will soon be available without a prescription. Making it easier to obtain the life-saving drug should save lives, but the devil, as they say, may be in the details.